Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumescent anesthesia for pain management during dynamic phototherapy in vertex actinic keratosis
2021-000304-38Phase 2Completed
- Sponsor
- CHU de Poitiers
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of lidocaine in actinic keratosis (AK) (2 arms), sponsored by CHU de Poitiers. Primary endpoint: Maximum pain score during dynamic phototherapy. Started Feb 2021; status: completed.
02
Drugs
lidocaine
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2021-000304-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000304-38.